Dosage of HIV drug may be ineffective for half of African Americans
Many African Americans may not be getting effective doses of the HIV drug maraviroc because they have two copies of a gene that makes…
Web Exclusives
Many oncology patients fail to receive treatment for depressio
Three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology show that 73% of cancer patients who have major depression are…
FDA approves new drug for Gaucher disease
On August 19, the U.S. Food and Drug Administration (FDA) approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1…
Positive RN staffing reduces stroke mortality
The ratio of RNs on the weekends affects mortality outcomes after stroke, according to a study in PLOS Medicine. Patients admitted to a unit…
Joint Commission releases Sentinel Event Alert
On Aug. 20, The Joint Commission released “Sentinel Event Alert 53: Managing risk during transition to new ISO tubing connector standards.” New ISO standards…
FDA approves new device that may boost number of lung transplants
On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated…
FDA approves new type of drug for insomnia
On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor…
Study: Smaller physician practices have lower preventable readmissions
A study published by Health Affairs has found that smaller physician practices have a lower rate of preventable hospital admissions compared to larger practices.…
FDA approves new drug for type 2 diabetes
On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic…
FDA approves new drug for skin infections
On August 6, the U.S. Food and Drug Administration (FDA) approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Read…
Genetic testing recommended for colorectal cancer patients
A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients.…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
Dosage of HIV drug may be ineffective for half of African Americans
Many African Americans may not be getting effective doses of the HIV drug maraviroc because they have two copies of a gene…
Many oncology patients fail to receive treatment for depressio
Three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology show that 73% of cancer patients who have major…
FDA approves new drug for Gaucher disease
On August 19, the U.S. Food and Drug Administration (FDA) approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the…
Positive RN staffing reduces stroke mortality
The ratio of RNs on the weekends affects mortality outcomes after stroke, according to a study in PLOS Medicine. Patients admitted to…
Joint Commission releases Sentinel Event Alert
On Aug. 20, The Joint Commission released “Sentinel Event Alert 53: Managing risk during transition to new ISO tubing connector standards.” New…
FDA approves new device that may boost number of lung transplants
On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for…
FDA approves new type of drug for insomnia
On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved…
Study: Smaller physician practices have lower preventable readmissions
A study published by Health Affairs has found that smaller physician practices have a lower rate of preventable hospital admissions compared to…
FDA approves new drug for type 2 diabetes
On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to…
FDA approves new drug for skin infections
On August 6, the U.S. Food and Drug Administration (FDA) approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin…
Genetic testing recommended for colorectal cancer patients
A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma,…